Sign In
Buy SYK
$337.03
+1.07 (+0.318%)
At Close: Aug 05, 2026
Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2022 Update
04:42am, Tuesday, 06'th Sep 2022 Seeking Alpha
Fundsmith filed their regulatory 13F Form on 8/15/2022. What were the latest stake disposals, increases and decreases? Click here to find out.
The All-Weather ETF Portfolio For Retirement
04:03am, Tuesday, 06'th Sep 2022 Seeking Alpha
A successful retirement can be attained by following some very simple suggestions. Click here for our all-weather ETF portfolio for retirement.
Why Stryker Remains a Top Health Care Name
11:01am, Thursday, 25'th Aug 2022
Stryker Corporation ( SYK , Financial) has long been one of my favorite health care names as the company provides some market-leading medical devices.
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
08:05pm, Monday, 22'nd Aug 2022 GlobeNewswire Inc.
Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.
Why This Dividend Stock Is a Buy
01:40pm, Thursday, 18'th Aug 2022 The Motley Fool
Stryker's medical devices reach more than 100 million patients each year.
Why This Dividend Stock Is a Buy
09:40am, Thursday, 18'th Aug 2022
Stryker's medical devices reach more than 100 million patients each year.
Should You Really Care About This Company's Short-Term Success?
10:00am, Friday, 05'th Aug 2022 The Motley Fool
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Should You Really Care About This Company's Short-Term Success?
06:00am, Friday, 05'th Aug 2022
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Stryker Is A Moat-Worthy Buy, Here's Why
08:15am, Wednesday, 03'rd Aug 2022
Stryker is a diversified medical technology company with strong sales growth, profitability, and a long history of dividend growth. It's well positioned to invest in strategic growth areas and benefit
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
02:07pm, Thursday, 28'th Jul 2022 Benzinga
Upgrades
According to Argus Research, the prior rating for Huntington Bancshares Inc (NASDAQ:HBAN) was changed from Hold to Buy. In the second quarter, Huntington Bancshares showed an EPS of $0.36, c
Stryker's (SYK) Q2 Earnings and Revenues Miss Estimates
02:04pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Where Stryker Stands With Analysts
01:17pm, Wednesday, 27'th Jul 2022 Benzinga
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
4
4
0
0
Last 30D
0
Walmart To $142? Plus This Analyst Raises Price Target On McDonald's
01:01pm, Wednesday, 27'th Jul 2022 Benzinga
Keybanc raised the price target for McDonald's Corporation (NYSE: MCD) from $285 to $290. However, Keybanc analyst Eric Gonzalez maintained the stock with an Overweight rating. McDonald's shares fel
Stryker (SYK) Lags Q2 Earnings and Revenue Estimates
10:25pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Stryker (SYK) delivered earnings and revenue surprises of -0.88% and 0.78%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker Corporation (SYK) CEO Kevin Lobo on Q2 2022 Results - Earnings Call Transcript
10:12pm, Tuesday, 26'th Jul 2022
Stryker Corporation (NYSE:SYK ) Q2 2022 Earnings Conference Call July 26, 2022 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Glenn Boehnlein - Chief Financial Officer
